Redeye retains its positive view of Lagercrantz after a Q4 report that aligned with our projections. Organic growth was decent at c5% and acquired growth remained solid. We expect to nudge up our estimates and valuation on the back of a solid report and a cautiously optimistic outlook.
LÄS MER
